nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anagrelide compared with hydroxyurea in essential thrombocythemia: a meta-analysis
|
Samuelson, Bethany |
|
2015 |
40 |
4 |
p. 474-479 |
artikel |
2 |
Aspirin dosing in cardiovascular disease prevention and management: an update
|
Ganjehei, Leila |
|
2015 |
40 |
4 |
p. 499-511 |
artikel |
3 |
Body mass index predicts major bleeding risks in patients on warfarin
|
Ogunsua, Adedotun A. |
|
2015 |
40 |
4 |
p. 494-498 |
artikel |
4 |
Consequences of treating false positive heparin-induced thrombocytopenia
|
Marler, Jacob |
|
2015 |
40 |
4 |
p. 512-514 |
artikel |
5 |
Effectiveness and safety of thrombolytic therapy in elderly patients with pulmonary embolism
|
İpek, Göktürk |
|
2015 |
40 |
4 |
p. 424-429 |
artikel |
6 |
Endovascular infection following inferior vena cava (IVC) filter insertion
|
Rottenstreich, Amihai |
|
2015 |
40 |
4 |
p. 452-457 |
artikel |
7 |
Erratum to: The effect of dabigatran and rivaroxaban on platelet reactivity and inflammatory markers
|
Zemer-Wassercug, Noa |
|
2015 |
40 |
4 |
p. 523 |
artikel |
8 |
Fructose induces prothrombotic phenotype in human endothelial cells
|
Cirillo, Plinio |
|
2015 |
40 |
4 |
p. 444-451 |
artikel |
9 |
Heart failure and pulmonary arteriovenous malformations in a patient with hereditary hemorrhagic telangiectasia type 2
|
Du, Juan |
|
2015 |
40 |
4 |
p. 515-519 |
artikel |
10 |
In vitro, antithrombotic and bleeding time studies of BMS-654457, a small-molecule, reversible and direct inhibitor of factor XIa
|
Wong, Pancras C. |
|
2015 |
40 |
4 |
p. 416-423 |
artikel |
11 |
In-vitro thrombogenicity assessment of flow diversion and aneurysm bridging devices
|
Girdhar, Gaurav |
|
2015 |
40 |
4 |
p. 437-443 |
artikel |
12 |
Platelet–endothelial cell interaction in brain microvessels of angiotensin II type-2 receptor knockout mice following transient bilateral common carotid artery occlusion
|
Fukuoka, Takuya |
|
2015 |
40 |
4 |
p. 401-405 |
artikel |
13 |
Platelet leukocyte aggregates and markers of platelet aggregation, immune activation and disease progression in HIV infected treatment naive asymptomatic individuals
|
Nkambule, Bongani B. |
|
2015 |
40 |
4 |
p. 458-467 |
artikel |
14 |
Preferences for anticoagulation therapy in atrial fibrillation: the patients’ view
|
Böttger, Björn |
|
2015 |
40 |
4 |
p. 406-415 |
artikel |
15 |
Prescription of enoxaparin is associated with decreasing pulmonary embolism mortality rate in Germany
|
Pütter, Carolin |
|
2015 |
40 |
4 |
p. 468-473 |
artikel |
16 |
Strategies and outcomes of periprocedural bridging therapy with low-molecular-weight heparin in patients with mechanical heart valves
|
Schulman, Jacqueline M. |
|
2015 |
40 |
4 |
p. 430-436 |
artikel |
17 |
Survival analysis in patients with ischemic stroke
|
Kawada, Tomoyuki |
|
2015 |
40 |
4 |
p. 520 |
artikel |
18 |
The changing characteristics of atrial fibrillation patients treated with warfarin
|
Putnam, Andrew |
|
2015 |
40 |
4 |
p. 488-493 |
artikel |
19 |
The contribution of apixaban renal clearance to total clearance
|
Frost, Charles |
|
2015 |
40 |
4 |
p. 521-522 |
artikel |
20 |
Why so little progress in therapeutic thrombolysis? The current state of the art and prospects for improvement
|
Gurewich, Victor |
|
2015 |
40 |
4 |
p. 480-487 |
artikel |